Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma.

MLA

Park, Bon, et al. “Exosomal MiR-155-5p Drives Ibrutinib Resistance in B-Cell Lymphoma.” Experimental Cell Research, vol. 442, no. 2, Oct. 2024, p. 114248. EBSCOhost, https://doi.org/10.1016/j.yexcr.2024.114248.

APA

Park, B., Choi, M. E., Ryu, K. J., Park, C., Choi, M., Yoon, S. E., Kim, W. S., Kim, H. H., Hong, J. Y., & Kim, S. J. (2024). Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma. Experimental Cell Research, 442(2), 114248. https://doi.org/10.1016/j.yexcr.2024.114248

Chicago

Park, Bon, Myung Eun Choi, Kyung Ju Ryu, Chaehwa Park, Minki Choi, Sang Eun Yoon, Won Seog Kim, Hyeon Ho Kim, Jung Yong Hong, and Seok Jin Kim. 2024. “Exosomal MiR-155-5p Drives Ibrutinib Resistance in B-Cell Lymphoma.” Experimental Cell Research 442 (2): 114248. doi:10.1016/j.yexcr.2024.114248.